Quinoline derivatives as CRTH2 receptor ligands
Details for Australian Patent Application No. 2007350688 (hide)
International Classifications
Event Publications
15 October 2009 PCT application entered the National Phase
PCT publication WO2008/119917 Priority application(s): WO2008/119917
29 July 2010 Alteration of Name
The name of the applicant has been altered to Pulmagen Therapeutics (Asthma) Limited 2008
24 February 2011 Application Accepted
Published as AU-B-2007350688
23 June 2011 Standard Patent Sealed
25 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser